Article Details
Retrieved on: 2025-09-22 18:37:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company announced it had advanced CT-388, its experimental obesity treatment, into a Phase 3 trial. The therapy entered Roche's pipeline through ...
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here